UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Five Year PSA-Failure Rates for Prostate Cancer Patients Treated with Dose-Escalated IMRT

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S430-S430

2011

Volltextzugriff (PDF)

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation

Oncogene, 2008-09, Vol.27 (40), p.5348-5353

2008

Volltextzugriff (PDF)

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

Prostate cancer and prostatic diseases, 2010-09, Vol.13 (3), p.228-237

2010

Volltextzugriff (PDF)

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence

Prostate cancer and prostatic diseases, 2010-12, Vol.13 (4), p.311-315

2010

Volltextzugriff (PDF)

Introduction to artificial neural networks for physicians: Taking the lid off the black box

The Prostate, 2001-01, Vol.46 (1), p.39-44

2001

Volltextzugriff (PDF)

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression

Prostate cancer and prostatic diseases, 2012-06, Vol.15 (2), p.150-156

2012

Volltextzugriff (PDF)

PD-07.03

Urology (Ridgewood, N.J.), 2006-11, Vol.68, p.24

2006

Volltextzugriff (PDF)

Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status

Prostate cancer and prostatic diseases, 2010-03, Vol.13 (1), p.47-51

2010

Volltextzugriff (PDF)

A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group

BJU international, 2001-01, Vol.87 (1), p.61-65

2001

Volltextzugriff (PDF)

PD-07.03: Comparison of site specific labeling of prostate biopsy specimens as compared to grouped labeling by side only

Urology (Ridgewood, N.J.), 2006, Vol.68, p.24-24

2006

Volltextzugriff (PDF)

Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens

Prostate cancer and prostatic diseases, 2008-06, Vol.11 (2), p.194-197

2008

Volltextzugriff (PDF)

2285

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S369

2006

Volltextzugriff (PDF)

2285: Clinical Predictors of Bone Metastasis Following Definitive Radiation Therapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S369-S369

2006

Volltextzugriff (PDF)

Evidence to Support that Serial Screening Decreases Prostate Cancer-Specific Mortality

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S112-S112

2005

Volltextzugriff (PDF)

Bicalutamide 150 mg in Addition to Standard Care Delays Progression to Bone Metastases in Patients with Locally Advanced Prostate Cancer: Analyses From the Second Analysis of the Early Prostate Cancer Program

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S286-S287

2005

Volltextzugriff (PDF)

Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss

Prostate cancer and prostatic diseases, 2002-01, Vol.5 (4), p.304-310

2002

Volltextzugriff (PDF)

Temporarily Deferred Therapy (Watchful Waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen Era

The Journal of urology, 2006, Vol.175 (1), p.266-267

2006

Volltextzugriff (PDF)

Bicalutamide 150 mg as adjuvant to radiotherapy significantly increases progression-free survival in early prostate cancer

International journal of radiation oncology, biology, physics, 2003-10, Vol.57 (2), p.S173-S174

2003

Volltextzugriff (PDF)

Frequent Overexpression of ETS-Related Gene-1 (ERG1) in Prostate Cancer Transcriptome

The Journal of urology, 2006-05, Vol.175 (5), p.1706-1707

2006

Volltextzugriff (PDF)

The assessment of treatment outcomes in metastatic prostate cancer: Changing endpoints

European journal of cancer (1990), 1997-04, Vol.33 (4), p.560-565

1997

Volltextzugriff (PDF)

RE: DETECTION OF CIRCULATING PROSTATE SPECIFIC ANTIGEN EXPRESSING PROSTATIC CELLS IN THE BONE MARROW OF RADICAL PROSTATECTOMY PATIENTS BY SENSITIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION

The Journal of urology, 2000, Vol.163 (1), p.253-253

2000

Volltextzugriff (PDF)

Bilateral Orchiectomy With or Without Flutamide for Metastatic Prostate Cancer

The Journal of urology, 1999-04, Vol.161 (4), p.1394-1394

1999

Volltextzugriff (PDF)

RE: DETECTION OF CIRCULATING PROSTATE SPECIFIC ANTIGEN EXPRESSING PROSTATIC CELLS IN THE BONE MARROW OF RADICAL PROSTATECTOMY PATIENTS BY SENSITIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION

The Journal of urology, 2000, Vol.163 (1), p.253-253

2000

Volltextzugriff (PDF)

Comparison of Megace, Stilphostrol, Megace Plus DES, or Streptozotocin in Metastatic Prostatic Cancer in Patients With Hormonal Failure and Prior Radiotherapy

The Journal of urology, 1989-04, Vol.141 (4), p.1033-1034

1989

Volltextzugriff (PDF)

An analysis of watchful waiting for prostate cancer and factors to predict secondary treatment

European urology supplements : official journal of the European Association of Urology, 2003-02, Vol.2 (1), p.38-38

2003

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Five Year PSA-Failure Rates for Prostate Cancer Patients Treated with Dose-Escalated IMRT

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence

Introduction to artificial neural networks for physicians: Taking the lid off the black box

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression

PD-07.03

Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status

A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group

PD-07.03: Comparison of site specific labeling of prostate biopsy specimens as compared to grouped labeling by side only

Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens

2285

2285: Clinical Predictors of Bone Metastasis Following Definitive Radiation Therapy for Prostate Cancer

Evidence to Support that Serial Screening Decreases Prostate Cancer-Specific Mortality

Bicalutamide 150 mg in Addition to Standard Care Delays Progression to Bone Metastases in Patients with Locally Advanced Prostate Cancer: Analyses From the Second Analysis of the Early Prostate Cancer Program

Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss

Temporarily Deferred Therapy (Watchful Waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen Era

Bicalutamide 150 mg as adjuvant to radiotherapy significantly increases progression-free survival in early prostate cancer

Frequent Overexpression of ETS-Related Gene-1 (ERG1) in Prostate Cancer Transcriptome

The assessment of treatment outcomes in metastatic prostate cancer: Changing endpoints

RE: DETECTION OF CIRCULATING PROSTATE SPECIFIC ANTIGEN EXPRESSING PROSTATIC CELLS IN THE BONE MARROW OF RADICAL PROSTATECTOMY PATIENTS BY SENSITIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION

Bilateral Orchiectomy With or Without Flutamide for Metastatic Prostate Cancer

RE: DETECTION OF CIRCULATING PROSTATE SPECIFIC ANTIGEN EXPRESSING PROSTATIC CELLS IN THE BONE MARROW OF RADICAL PROSTATECTOMY PATIENTS BY SENSITIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION

Comparison of Megace, Stilphostrol, Megace Plus DES, or Streptozotocin in Metastatic Prostatic Cancer in Patients With Hormonal Failure and Prior Radiotherapy

An analysis of watchful waiting for prostate cancer and factors to predict secondary treatment

Suchergebnisse filtern